David B Musket insider trades: Capricor Therapeutics (CAPR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
33 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 12, 2023 | CAPR | ↑ Buy | 410 | $2.75 | $1K | Direct | Oct 13, 2023 (1d) |
| Oct 9, 2023 | CAPR | ↑ Buy | 5,083 | $2.82 | $14K | Direct | Oct 11, 2023 (2d) |
| Oct 4, 2023 | CAPR | ↑ Buy | 2,500 | $2.90 | $7K | Direct | Oct 6, 2023 (2d) |
| Jun 29, 2022 | CAPR | ↓ Sell | 28,215 | $3.77 | $106K | Direct | Jul 1, 2022 (2d) |
| Jun 27, 2022 | CAPR | ↓ Sell | 17,775 | $4.44 | $79K | Direct | Jun 29, 2022 (2d) |
| May 9, 2017 | CAPR | ↑ Buy | 25,000 | $3.10 | $78K | Direct | May 11, 2017 (2d) |
| Jan 21, 2015 | CAPR | ↑ Buy | 70,962 | $3.52 | $250K | By SEP FBO David B. Musket, Pershing LLC | Jan 22, 2015 (1d) |
| Nov 21, 2007 | MZT | ↓ Sell | 451,170 | $0.10 | $45K | By various ProMed Funds | Nov 26, 2007 (5d) |
| Nov 20, 2007 | MZT | ↓ Sell | 1,259,400 | $0.10 | $126K | By various ProMed Funds | Nov 21, 2007 (1d) |
| Dec 29, 2006 | CONR | ↓ Sell | 242,591 | $31.32 | $7.6M | Direct | Dec 29, 2006 (0d) |
| Dec 27, 2006 | CONR | ↓ Sell | 87,400 | $31.37 | $2.7M | Direct | Dec 27, 2006 (0d) |
| Dec 22, 2006 | CONR | ↓ Sell | 145,009 | $31.44 | $4.6M | Direct | Dec 22, 2006 (0d) |
| Dec 20, 2006 | CONR | ↓ Sell | 130,000 | $31.52 | $4.1M | Direct | Dec 20, 2006 (0d) |
| Dec 19, 2006 | CONR | ↓ Sell | 52,500 | $31.56 | $1.7M | Sold by Lehman Brothers | Dec 20, 2006 (1d) |
| Dec 18, 2006 | CONR | ↓ Sell | 40,000 | $31.21 | $1.2M | Sold by ProMed Offshore Fund II, L.P. | Dec 20, 2006 (2d) |
| Dec 18, 2006 | CONR | ↓ Sell | 34,728 | $31.21 | $1.1M | Sold by ProMed Partners, L.P. | Dec 20, 2006 (2d) |
| Dec 18, 2006 | CONR | ↓ Sell | 4,471 | $31.21 | $140K | Sold by ProMed Offshore Fund, Ltd. | Dec 20, 2006 (2d) |
| Dec 18, 2006 | CONR | ↓ Sell | 1,300 | $31.21 | $41K | Sold by ProMed Partners II. L.P. | Dec 20, 2006 (2d) |
| May 24, 2006 | CONR | ↓ Sell | 61,000 | $23.34 | $1.4M | Held by ProMed Partners, L.P. | May 25, 2006 (1d) |
| May 24, 2006 | CONR | ↓ Sell | 4,800 | $23.34 | $112K | Held by ProMed Offshore Fund, Ltd. | May 25, 2006 (1d) |
| Mar 9, 2006 | SPRX | ↓ Sell | 277,050 | $0.23 | $63K | Indirect | Mar 16, 2007 (372d) |
| Feb 28, 2006 | CONR | ↓ Sell | 67,500 | $25.86 | $1.7M | Held by ProMed Partners, L.P. | Feb 28, 2006 (0d) |
| Feb 28, 2006 | CONR | ↓ Sell | 13,700 | $25.86 | $354K | Held by ProMed Partners II, L.P. | Feb 28, 2006 (0d) |
| Feb 28, 2006 | CONR | ↓ Sell | 4,500 | $25.36 | $114K | Held by ProMed Offshore Fund, Ltd. | Feb 28, 2006 (0d) |
| Feb 10, 2006 | SPRX | ↓ Sell | 240,642 | $0.25 | $61K | Indirect | Mar 16, 2007 (399d) |
| Jul 28, 2005 | AEGN | ↓ Sell | 33,700 | $0.65 | $22K | Indirect | Aug 18, 2005 (21d) |
| Apr 27, 2005 | AEGN | ↑ Buy | 5,700 | $0.96 | $5K | Indirect | Jun 15, 2005 (49d) |
| Apr 26, 2005 | AEGN | ↑ Buy | 50,929 | $0.99 | $50K | Indirect | Jun 15, 2005 (50d) |
| Apr 25, 2005 | AEGN | ↑ Buy | 35,000 | $0.99 | $35K | Indirect | Jun 14, 2005 (50d) |
| Apr 22, 2005 | AEGN | ↑ Buy | 25,000 | $0.98 | $24K | Indirect | Jun 14, 2005 (53d) |
| Apr 21, 2005 | AEGN | ↑ Buy | 33,000 | $0.88 | $29K | Indirect | Jun 14, 2005 (54d) |
| Oct 6, 2004 | SPRX | ↑ Buy | 515,203 | $0.39 | $202K | Indirect | Mar 16, 2007 (891d) |
| May 12, 2004 | SPRX | ↑ Buy | 2,489 | $1.80 | $4K | Indirect | Mar 16, 2007 (1038d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CAPR insiders
Open-market trades in the last 12 months
About David B Musket's insider trades
David B Musket is an insider at Capricor Therapeutics (CAPR). Since May 12, 2004, David has reported 12 open-market purchases worth $701K and 21 sales worth $27.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (18 filings), option exercises (5 filings), shares returned to the company (3 filings), conversions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CAPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.